SAM-based Genome Editing to Obtain Isogenic Cell Lines Overexpressing Human CD5 Protein
暂无分享,去创建一个
[1] F. Végran,et al. Alternative Splicing in Cancer and Immune Cells , 2022, Cancers.
[2] Howard Y. Chang,et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing , 2021, Cell.
[3] M. Brenner,et al. Chimeric Antigen Receptors for T-Cell Malignancies , 2019, Front. Oncol..
[4] Timothy E. Reddy,et al. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome , 2017, Nature Biotechnology.
[5] D. Pezzoli,et al. Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation , 2017, Scientific Reports.
[6] Neville E Sanjana,et al. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening , 2016, Nature Protocols.
[7] Antonia A. Dominguez,et al. Transcriptional regulation of hepatic lipogenesis , 2015, Nature Reviews Molecular Cell Biology.
[8] Christopher M. Vockley,et al. Epigenome editing by a CRISPR/Cas9-based acetyltransferase activates genes from promoters and enhancers , 2015, Nature Biotechnology.
[9] Alexandro E. Trevino,et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.
[10] P. Bradding,et al. CADM1 is expressed as multiple alternatively spliced functional and dysfunctional isoforms in human mast cells , 2013, Molecular immunology.
[11] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[12] M. Kumar,et al. Systematic determination of the packaging limit of lentiviral vectors. , 2001, Human gene therapy.